Porcine Reproductive & Respiratory Syndrome roadmap:
Vaccines
Roadmap for development of a candidate vaccine for PRRSV
Download PRRSV Vaccine Roadmap6
Subunit vaccines
Development of a cross protective/multivalent subunit vaccine
Research Question
- The development of an effective subunit vaccine that gives broad cross-protective sterile immunity but doesn’t contribute to virus evolution
Research Gaps and Challenges
- Having it multivalent
- Having the protective response involving both VN-Abs and CTC
Solution Routes
- Establishing that there isn’t interference between the various antigens
- Monitoring the immune response following immunisation with the various combinations of candidate immunogens
- Challenge experiments with the various vaccine candidates
- If a multivalent vaccine isn’t possible then strain specific autologous vaccines based on recognised antigen combinations will be needed
- Production of virus-like particles containing all the desired surface proteins of PRRSV
Dependencies
- Identifying a combination of antigens for expression by a suitable expression vector or a common single Ag to which immune responses are normally suppressed
- The availability of suitable adjuvants to stimulate strong CTC and VNAb responses
- Identifying expression systems that give correct antigen conformation
Projects
What activities are planned or underway?
Generating antibodies broadly neutralising porcine reproductive and respiratory syndrome virus (PRRSV)
Planned Completion date 31/12/2025
Source Countries:
Denmark
Identification of interferon stimulated genes that control Toxoplasma in pig macrophages
Planned Completion date 01/03/2026
Source Countries:
United Kingdom